Compass Therapeutics, Inc. (CMPX) vs Veraxa Biotech AG (VRXA)

Compass Therapeutics, Inc. CMPX 0.86 −4.44%
Veraxa Biotech AG VRXA 1.11 +0.91%

Compass Therapeutics, Inc. and Veraxa Biotech AG are both Biotechnology companies. Compass Therapeutics, Inc. and Veraxa Biotech AG are of similar size ($162.5M and $161.5M).

Metric	CMPX	VRXA	Biotechnology median
P/E	n/m	—	8.50
P/S	n/m	—	9.71
P/B	0.97	—	2.13
Price to free cash flow	n/m	—	20.82
EV/EBITDA	0.17	—	0.64
EV/Sales	n/m	—	9.21
Earnings yield	(46.51%)	—	(33.15%)
Free cash flow yield	(35.09%)	—	(25.50%)

Metric	CMPX	VRXA	Biotechnology median
Gross margin	0.00%	—	65.16%
Operating margin	0.00%	—	0.00%
Net margin	0.00%	—	0.00%
Free cash flow margin	0.00%	—	0.00%
Return on equity	(56.66%)	—	(56.36%)
Return on assets	(47.87%)	—	(48.04%)
Return on invested capital	0.00%	—	0.00%

Metric	CMPX	VRXA	Biotechnology median
Revenue growth (TTM)	—	—	6.02%
EPS growth (last fiscal year)	(16.67%)	—	30.26%
Revenue growth, 5-year CAGR	—	—	9.41%
Net income growth, 5-year CAGR	0.00%	—	0.00%

Metric	CMPX	VRXA	Biotechnology median
Debt to equity	0.00	—	0.00
Current ratio	11.22	—	4.72
Net debt to EBITDA	2.86	—	0.96

Metric	CMPX	VRXA	Biotechnology median
Dividend yield	—	—	0.09%
Payout ratio	—	—	—

Metric	CMPX	VRXA	Biotechnology median
Market cap	161.49m	162.50m	135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack